Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LUNG - Pulmonx Corp

IEX Last Trade
6.17
-2.240   -36.305%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:18:40 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%
$8.41
-2.24
-26.63%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
12%
Profitability 8%
Dept financing 15%
Liquidity 75%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.16%
1 Month
-6.81%
3 Months
-25.33%
6 Months
1.82%
1 Year
-51.46%
2 Year
-21.53%
Key data
Stock price
$6.17
P/E Ratio 
-4.95
DAY RANGE
$6.30 - $8.41
EPS 
-$1.50
52 WEEK RANGE
$5.77 - $14.84
52 WEEK CHANGE
-$52.87
MARKET CAP 
286.597 M
YIELD 
N/A
SHARES OUTSTANDING 
39.153 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/28/2024
BETA 
1.44
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$239,961
AVERAGE 30 VOLUME 
$235,618
Company detail
CEO: Glendon E. French
Region: US
Website: pulmonx.com
Employees: 250
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Pulmonx Corporation provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service. It serves emphysema patients in the United States, Europe, the Middle East, Africa, Asia-Pacific and internationally.

Recent news